| Safety and Performance Study of the Optimum Transcatheter Aortic Valve (NCT04076150) | Thubrikar Aortic Valve, Inc. | 2022-05-18 |
| Colibri Transcatheter Aortic Heart Valve System Study (NCT04029844) | Colibri Heart Valve LLC | 2021-09-15 |
| A Registry to Assess the Efficacy and Safety of Transcatheter Treatment for Aortic Valve Disease at the IRCCS Policlinico San Matteo Foundation in Pavia (Italy). (NCT07596394) | Fondazione IRCCS Policlinico San Matteo di Pavia | 2021-03-16 |
| Intravenous Iron Supplement for Iron Deficiency in Patients With Severe Aortic Stenosis (NCT04206228) | Oslo University Hospital | 2020-01-13 |
| Improved HRV, Inflammation Markers and Endothelial Function After TAVI (NCT04286893) | University Medical Centre Ljubljana | 2019-07-09 |
| Evaluate the Transcatheter Artificial Aortic Valve and Transcatheter Artificial Heart Values Delivery System (NCT03788590) | Ningbo Jenscare Biotechnology Co., Ltd. | 2019-02-23 |
| CONFIDENCE Registry to Assess Safety and Performance of Portico System to Treat Patients With Severe Aortic Stenosis. (NCT03752866) | Abbott Medical Devices | 2018-10-25 |
| Safety and Efficacy of SYM-SV/DS-002 in Patients With Severe Aortic Stenosis (NCT03004599) | Medico's Hirata Inc. | 2016-11-01 |
| Primary Non-invasive Cardiac Computed Tomography Versus Routine Invasive Angiography Prior to TAVI (NCT03291925) | BC Centre for Improved Cardiovascular Health | 2016-11-01 |
| HLT transfemOral Replacement of aortIc Valve Via transcatherteriZatiON (NCT02157142) | HLT Inc. | 2014-08-01 |
| HLT transfemOral Replacement of aortIc Valve Via transcatherteriZatiON CANADA (NCT02159794) | HLT Inc. | 2014-08-01 |
| Open-label, Randomized Trial in Participants Undergoing TAVR to Determine Safety & Efficacy of Bivalirudin vs UFH (NCT01651780) | The Medicines Company | 2012-10-01 |
| Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement (NCT01675440) | Medtronic Cardiovascular | 2012-08-01 |
| Myocardial Flow Reserve in Severe AS Without Obstructive Coronary Artery Disease (NCT02575768) | Samsung Medical Center | 2012-06-01 |
| Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). (NCT01586910) | Medtronic Cardiovascular | 2012-04-01 |
| Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement (NCT01240902) | Medtronic Cardiovascular | 2010-12-10 |
| SOURCE XT REGISTRY (NCT01238497) | Edwards Lifesciences | 2010-09-01 |
| CoreValve Advance International Post Market Study (NCT01074658) | Medtronic Cardiac Rhythm and Heart Failure | 2010-03-01 |
| Severe Aortic Stenosis and Acquired Von Willebrand´s Disease: The Impact of Desmopressin in Valve-Replacement Surgery (NCT01994330) | Pontificia Universidad Catolica de Chile | 2009-06-01 |